Amphastar Pharmaceuticals, Inc.
AMPH
Revenue
183.11M
▼-8.74M▼-4.55%
3 Months ChangeAssets
1.63B
▼-36.92M▼-2.22%
3 Months ChangeLiabilities
840.49M
▼-48.98M▼-5.51%
3 Months ChangeFree Cash Flow
24.38M
▼-22.12M▼-47.57%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-06
Form 8-K
ID: 0001297184-26-000015
2026-03-06
Form 8-K
ID: 0001297184-26-000013
2026-02-26
Form 8-K
ID: 0001297184-26-000007
2026-01-12
Form 8-K
ID: 0001297184-26-000002
2025-11-06
Form 10-Q
ID: 0001297184-25-000064
2025-11-06
Form 8-K
ID: 0001297184-25-000062
2025-10-24
Form 8-K
ID: 0001297184-25-000058
2025-09-18
Form 8-K
ID: 0001297184-25-000054
2025-08-12
Form 8-K
ID: 0001558370-25-011134
2025-08-07
Form 10-Q
ID: 0001297184-25-000050